A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group




TekijätAlmangush Alhadi, Jouhi Lauri, Atula Timo, Haglund Caj, Mäkitie Antti A, Hagström Jaana, Leivo Ilmo

KustantajaSPRINGERNATURE

Julkaisuvuosi2022

JournalBritish Journal of Cancer

Tietokannassa oleva lehden nimiBRITISH JOURNAL OF CANCER

Lehden akronyymiBRIT J CANCER

Vuosikerta126

Numero11

Aloitussivu1589

Lopetussivu1594

Sivujen määrä6

ISSN0007-0920

eISSN1532-1827

DOIhttps://doi.org/10.1038/s41416-022-01708-7

Verkko-osoitehttps://www.nature.com/articles/s41416-022-01708-7

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/175821171


Tiivistelmä

Background
The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC).

Methods
A total of 182 patients treated for OPSCC were included in this study. Assessment of TILs was conducted on tumour sections stained with standard haematoxylin and eosin (HE) staining. We used the scoring criteria proposed by the International Immuno-Oncology Biomarker Working Group.

Results
The multivariable analysis showed that TILs associated with disease-specific survival with a hazard ratio (HR) of 2.13 (95% CI 1.14–3.96; P = 0.017). Similarly, TILs associated significantly with overall survival with HR of 1.87 (95% CI 1.11–3.13; P = 0.018). In a sub-analysis of HPV-positive and HPV-negative cases separately, TILs showed a significant prognostic value in both groups (P < 0.05).

Conclusion
The evaluation of TILs as proposed by the International Immuno-Oncology Biomarker Working Group is a simple and promising method in prediction of survival of OPSCC. It is easily applicable and after further validation can be implemented in the routine pathological report as a basic immune parameter.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 23:33